Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 1
2004 2
2005 2
2006 6
2007 8
2008 8
2009 9
2010 12
2011 7
2012 22
2013 16
2014 22
2015 28
2016 30
2017 26
2018 23
2019 24
2020 33
2021 34
2022 22
2023 15
2024 26
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Results by year

Filters applied: . Clear all
Page 1
Rasmussen's encephalitis: Early diagnostic criteria in children.
Villeneuve N, Lépine A, Girard N, Guedj E, Daquin G. Villeneuve N, et al. Among authors: guedj e. Rev Neurol (Paris). 2022 Sep;178(7):666-674. doi: 10.1016/j.neurol.2022.03.012. Epub 2022 May 11. Rev Neurol (Paris). 2022. PMID: 35568516 Review.
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3.
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, van de Giessen E, Van Weehaeghe D, Morbelli S. Guedj E, et al. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):632-651. doi: 10.1007/s00259-021-05603-w. Epub 2021 Dec 9. Eur J Nucl Med Mol Imaging. 2022. PMID: 34882261 Free PMC article.
Depressive Symptoms and Amyloid Pathology.
Wiels WA, Oomens JE, Engelborghs S, Baeken C, von Arnim CAF, Boada M, Didic M, Dubois B, Fladby T, van der Flier WM, Frisoni GB, Fröhlich L, Gill KD, Grimmer T, Hildebrandt H, Hort J, Itoh Y, Iwatsubo T, Klimkowicz-Mrowiec A, Lee DY, Lleó A, Martinez-Lage P, de Mendonça A, Meyer PT, Kapaki EN, Parchi P, Pardini M, Parnetti L, Popp J, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Sánchez-Juan P, Santana I, Sarazin M, Scarmeas N, Skoog I, Snyder PJ, Sperling RA, Villeneuve S, Wallin A, Wiltfang J, Zetterberg H, Ossenkoppele R, Verhey FRJ, Vos SJB, Visser PJ, Jansen WJ; Amyloid Biomarker Study group; Alzheimer’s Disease Neuroimaging Initiative (ADNI), the A4 Study group, Dominantly Inherited Alzheimer Network (DIAN), European Prevention of Alzheimer’s Dementia (EPAD) consortium, Fundació ACE Healthy Brain Initiative (FACEHBI), Harvard Aging Brain Stud; Alcolea D, Altomare D, Baiardi S, Baldeiras I, Bateman RJ, Blennow K, Bottlaender M, den Braber A, van Buchem MA, Byun MS, Cerman J, Chen K, Chipi E, Day GS, Drzezga A, Eckerström M, Ekblad LL, Epelbaum S, Förster S, Fortea J, Freund-Levi Y, Frings L, Guedj E, Hausner L, Hellwig S, Huey ED, Jiménez-Bonilla JF, Johnson KA, Juaristi A… See abstract for full author list ➔ Wiels WA, et al. Among authors: guedj e. JAMA Psychiatry. 2025 Mar 1;82(3):296-310. doi: 10.1001/jamapsychiatry.2024.4305. JAMA Psychiatry. 2025. PMID: 39841452
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ; Amyloid Biomarker Study Group; Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Flier WM, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Frings L, Frisoni GB, Fröhlich L, Gabryelewicz T, Gertz HJ, Gill KD, Gkatzima O, Gómez-Tortosa E, Grimmer T, Guedj E, Habeck CG, Hampel H, Handels R, Hansson O, Hausner L, Hellwig S, Heneka MT, Herukka SK, Hildebrandt H, Hodges J, Hort J, Huang CC, Iriondo AJ, Itoh Y, Ivanoiu A, Jagust WJ, Jessen F, Johannsen P, Johnson KA, Kandimalla R, Kapaki EN, Kern S, Kilander L, Klimkowicz-Mrowiec A, Klunk WE, Koglin N, Kornhuber J, Kramberger MG, Kuo HC, Van Laere K, Landau SM, Landeau B, Lee DY, de Leon M, Leyton CE, Lin KJ, Lleó A, Löwenmark M, Madsen K, Maier W, Marcusson J, Marquié M, Martinez-Lage P,… See abstract for full author list ➔ Jansen WJ, et al. Among authors: guedj e. JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216. JAMA Neurol. 2022. PMID: 35099509 Free PMC article.
Metabolic Brain PET Connectivity.
Horowitz T, Doyen M, Caminiti SP, Yakushev I, Verger A, Guedj E. Horowitz T, et al. Among authors: guedj e. PET Clin. 2025 Jan;20(1):1-10. doi: 10.1016/j.cpet.2024.09.014. Epub 2024 Oct 30. PET Clin. 2025. PMID: 39482220 Review.
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, Guedj E, Furtner J, Fraioli F, Huang RY, Johnson DR, Deroose CM, Herrmann K, Vogelbaum M, Chang S, Tonn JC, Weller M, Wen PY, van den Bent MJ, Verger A, Ivanidze J, Galldiks N. Albert NL, et al. Among authors: guedj e. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3662-3679. doi: 10.1007/s00259-024-06783-x. Epub 2024 Jun 20. Eur J Nucl Med Mol Imaging. 2024. PMID: 38898354 Free PMC article.
Innovative treatments for meningiomas.
Graillon T, Tabouret E, Salgues B, Horowitz T, Padovani L, Appay R, Farah K, Dufour H, Régis J, Guedj E, Barlier A, Chinot O. Graillon T, et al. Among authors: guedj e. Rev Neurol (Paris). 2023 Jun;179(5):449-463. doi: 10.1016/j.neurol.2023.03.006. Epub 2023 Mar 21. Rev Neurol (Paris). 2023. PMID: 36959063 Review.
Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers.
Bouteloup V, Villain N, Vidal JS, Gonzalez-Ortiz F, Yuksekel I, Santos C, Schraen-Maschken S, Pellegrin I, Lehmann S, Blennow K, Chêne G, Hanon O, Dufouil C, Planche V; MEMENTO and the BALTAZAR Study Groups. Bouteloup V, et al. JAMA Neurol. 2025 May 1;82(5):506-515. doi: 10.1001/jamaneurol.2025.0142. JAMA Neurol. 2025. PMID: 40181683 Free PMC article.
Lecanemab approval in EU: what should we be ready for?- the EANM perspective.
Yakushev I, Verger A, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Grimmer T, Tolboom N, Traub-Weidinger T, Guedj E, Van Weehaeghe D. Yakushev I, et al. Among authors: guedj e. Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1607-1610. doi: 10.1007/s00259-025-07066-9. Eur J Nucl Med Mol Imaging. 2025. PMID: 39789225 Free PMC article. No abstract available.
344 results